Mercy has partnered with Johnson & Johnson Medical Devices Companies (JJMDC) on a research collaboration using a real-world clinical data platform the health system established to monitor the performance of medical devices.
Mercy’s director of outcomes research Dr. Joseph Drozda says the data platform was key to ensuring health devices were serving their purpose.
“We began this project to make sure the devices Mercy uses work for patients,” Drozda said in a statement. “With more than 8,000 new medical devices entering the market each year, it’s critical that we find better ways to evaluate their performance.”
The Mercy-JJMDC partnership comes some months after a separate partnership between Mercy and another device manufacturer announced a similar collaborative effort.
“Not only does Mercy have diverse data, we have the data platform, quality, scale and sophisticated data scientists to turn this data into meaningful information,” Drozda said. “That’s critical where patient outcomes are concerned.”
To read more about the partnership in the full press release, click here.